Quest Diagnostics Inc vs Five9 Inc — how do they compare? Quest Diagnostics Inc trades at $236.29 (market cap $26.24B), while Five9 Inc trades at $33.74 (market cap $2.33B). The key difference: Quest Diagnostics Inc is far larger — about 11.3× Five9 Inc's market cap, and Quest Diagnostics Inc pays a 1.45% dividend while Five9 Inc pays none. Which is the better fit depends on your goals.
| DGX | FIVN | |
|---|---|---|
Market Cap | $26.24B | $2.33B |
Sector | Health | Technology |
52-Week High | $238.50 | $34.48 |
52-Week Low | $173.49 | $13.61 |
Enterprise Value | $32.00B | $2.48B |
Dividend Yield | 1.45% | — |
Trailing returns across standard periods
Latest headlines on both assets
Quest Diagnostics is a leading independent provider of diagnostic testing, information, and services in the U.S. The company generates over 95% of its revenue through clinical testing, anatomic pathology, esoteric testing, and substance abuse testing with specimens collected at its national network of roughly 2,300 patient service centers, as well as multiple doctors offices and hospitals. The firm also runs a much smaller diagnostic solutions segment that provides clinical trials testing, risk assessment services, and information technology solutions.
Read more on DGX →Five9 provides cloud-native contact center software that enables digital customer service, sales, and marketing engagement. The company's Virtual Contact Center platform combines core telephony functionality, omnichannel engagement capabilities, and various software modules into a unified cloud contact-center-as-a-service, or CCaaS, platform. Five9's artificial intelligence and automation portfolio supplements and enhances the firm's core CCaaS offerings, including solutions for digital self-service, agent assist technology, and workflow automation. Five9 also offers workforce optimization products that optimize call center efficiency through workforce management solutions, manage interaction quality, and track agent performance.
Read more on FIVN →